Abstract
Autism Spectrum Disorders (ASD) are characterized by dysfunction in three core symptom domains: social impairments, communication impairments, and repetitive behaviours with restricted interests. Oxytocin (OXT) and the structurally similar peptide arginine vasopressin (AVP), may play a role in the etiology of these disorders, especially in the social difficulties domain. Oxytocin is involved in milk let-down and uterine contractions at a peripheral level, while in the brain it predominantly has a neuromodulatory function on affiliative and social behavior. Abnormalities of OXT in ASD are herein reviewed, using blood studies, neuroimaging, and translational research. Genetic abnormalities in OXT have also been consistently reported in ASD. Clinical trials with OXT are currently aimed at reducing social impairments and repetitive behaviours. Finally, the current limitations and prospects for the future of OXT treatment in ASD are discussed.
Keywords: Autism spectrum disorders, social behaviour, oxytocin, arginine vasopressin, translational research, therapeutics, prohormone, endogenous, Vineland Adaptive Behavior Scales, ADP-ribosyl, cyclase activity, neuroimaging, neuromodulatory, arginine vasopressin (AVP), uterine
Current Psychopharmacology
Title: The Role of Oxytocin in Autism Spectrum Disorders
Volume: 1
Author(s): Roberto Canitano and Valeria Scandurra
Affiliation:
Keywords: Autism spectrum disorders, social behaviour, oxytocin, arginine vasopressin, translational research, therapeutics, prohormone, endogenous, Vineland Adaptive Behavior Scales, ADP-ribosyl, cyclase activity, neuroimaging, neuromodulatory, arginine vasopressin (AVP), uterine
Abstract: Autism Spectrum Disorders (ASD) are characterized by dysfunction in three core symptom domains: social impairments, communication impairments, and repetitive behaviours with restricted interests. Oxytocin (OXT) and the structurally similar peptide arginine vasopressin (AVP), may play a role in the etiology of these disorders, especially in the social difficulties domain. Oxytocin is involved in milk let-down and uterine contractions at a peripheral level, while in the brain it predominantly has a neuromodulatory function on affiliative and social behavior. Abnormalities of OXT in ASD are herein reviewed, using blood studies, neuroimaging, and translational research. Genetic abnormalities in OXT have also been consistently reported in ASD. Clinical trials with OXT are currently aimed at reducing social impairments and repetitive behaviours. Finally, the current limitations and prospects for the future of OXT treatment in ASD are discussed.
Export Options
About this article
Cite this article as:
Canitano Roberto and Scandurra Valeria, The Role of Oxytocin in Autism Spectrum Disorders, Current Psychopharmacology 2012; 1 (2) . https://dx.doi.org/10.2174/2211556011201020178
DOI https://dx.doi.org/10.2174/2211556011201020178 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Innate Immunity and the Heart
Current Pharmaceutical Design Assessing the Serum Levels of Ferritin and Selenium in three Important Infections of Childhood, Compared to a Control Group
Current Nutrition & Food Science Accessing the Blood-Brain Barrier to Treat Brain Disorders
Current Nanomedicine Platelet SERT as a Peripheral Biomarker of Serotonergic Neurotransmission in the Central Nervous System
Current Medicinal Chemistry Stretch, Shrink, and Shatter the Rhythms: The Intrinsic Circadian Period in Mania and Depression
CNS & Neurological Disorders - Drug Targets Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience
Current Pharmaceutical Design Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems
Current Neuropharmacology Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders
Current Drug Targets PREFACE
Current Neuropharmacology Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
Current Pharmaceutical Design Cell Transplantation: A Future Therapy for Narcolepsy?
CNS & Neurological Disorders - Drug Targets Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer’s Disease? Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Actions of Alcohol in Brain: Genetics, Metabolomics, GABA Receptors, Proteomics and Glutamate Transporter GLAST/EAAT1
Current Molecular Pharmacology Intervertebral Disc and Nucleus Replacement Devices and Instrumentations
Recent Patents on Biomedical Engineering (Discontinued) Sirtuin3 in Neurological Disorders
Current Drug Research Reviews Premorbid and Illness-related Social Difficulties in Eating Disorders: An Overview of the Literature and Treatment Developments
Current Neuropharmacology Adolescent Peer Victimization and PTSD Risk
Adolescent Psychiatry Anticoagulant Therapy for Acute Lung Injury or Pneumonia
Current Drug Targets Hangover Research Needs: Proceedings of the 5th Alcohol Hangover Research Group Meeting
Current Drug Abuse Reviews